D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 65 Citations 15,861 218 World Ranking 1410 National Ranking 718

Overview

What is he best known for?

The fields of study he is best known for:

  • Immune system
  • Antibody
  • Virus

Guido Ferrari mostly deals with Virology, Immunology, Antibody, Virus and Epitope. His biological study spans a wide range of topics, including AIDS Vaccines and Immunization. He has included themes like Cytotoxic T cell and HIV vaccine in his Immunology study.

His Antibody study integrates concerns from other disciplines, such as Antigen and AIDSVAX. His study in Virus is interdisciplinary in nature, drawing from both Mutation, Adenoviridae and Heterologous. Within one scientific family, he focuses on topics pertaining to ELISPOT under Epitope, and may sometimes address concerns connected to Cellular immunity and MHC class I.

His most cited work include:

  • Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial (1399 citations)
  • The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection (560 citations)
  • Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys (406 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Virology, Immunology, Antibody, Immune system and Antibody-dependent cell-mediated cytotoxicity. His Virology research includes elements of Epitope, Cytotoxic T cell and HIV vaccine. The various areas that he examines in his HIV vaccine study include Regimen and AIDS Vaccines.

All of his Immunology and T cell, CD8, Vaccine efficacy, Antigen and Immunogenicity investigations are sub-components of the entire Immunology study. His Vaccine efficacy study combines topics in areas such as Vaccine trial and AIDSVAX. His Antibody study frequently draws connections between related disciplines such as Effector.

He most often published in these fields:

  • Virology (66.02%)
  • Immunology (60.62%)
  • Antibody (47.49%)

What were the highlights of his more recent work (between 2018-2021)?

  • Antibody (47.49%)
  • Virology (66.02%)
  • Immunology (60.62%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Antibody, Virology, Immunology, HIV vaccine and Antibody-dependent cell-mediated cytotoxicity. Guido Ferrari has researched Antibody in several fields, including Effector, Immune system and Vaccination. His research in Virology is mostly focused on Virus.

His Immunology study incorporates themes from HVTN 505, Receptor and Interleukin 15. His HIV vaccine research is multidisciplinary, incorporating elements of Regimen and Immunogenicity. His study looks at the relationship between Antibody-dependent cell-mediated cytotoxicity and fields such as Antigen, as well as how they intersect with chemical problems.

Between 2018 and 2021, his most popular works were:

  • Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk (27 citations)
  • Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques. (27 citations)
  • Curing HIV: Seeking to Target and Clear Persistent Infection (23 citations)

In his most recent research, the most cited papers focused on:

  • Immune system
  • Antibody
  • Virus

His primary areas of study are Antibody, HIV vaccine, Immunogenicity, Antibody-dependent cell-mediated cytotoxicity and Immunology. His Antibody research is multidisciplinary, incorporating perspectives in Virus, Viral load and Virology. Guido Ferrari specializes in Virology, namely Neutralization.

His work in HIV vaccine tackles topics such as Vaccination which are related to areas like Immune system, Regimen, Reactogenicity and Immunoglobulin G. The study incorporates disciplines such as Epitope, Antigen and Neutralizing antibody in addition to Antibody-dependent cell-mediated cytotoxicity. His studies deal with areas such as Fc receptor, Cytotoxicity and Rhesus macaque as well as Epitope.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner.
The New England Journal of Medicine (2012)

1662 Citations

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection

Nilu Goonetilleke;Michael K.P. Liu;Jesus F. Salazar-Gonzalez;Guido Ferrari.
Journal of Experimental Medicine (2009)

708 Citations

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

Dan H. Barouch;Dan H. Barouch;Jinyan Liu;Hualin Li;Lori F. Maxfield.
Nature (2012)

467 Citations

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays.

Jeffrey R Currier;Ellen G Kuta;Ellen Turk;Lyndsay B Earhart.
Journal of Immunological Methods (2002)

453 Citations

Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination

Nicole L. Yates;Nicole L. Yates;Hua Xin Liao;Hua Xin Liao;Youyi Fong;Allan DeCamp.
Science Translational Medicine (2014)

383 Citations

Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family

Mattia Bonsignori;Justin Pollara;M. Anthony Moody;Michael D. Alpert.
Journal of Virology (2012)

374 Citations

Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

Hua Xin Liao;Mattia Bonsignori;S. Munir Alam;Jason S. McLellan.
Immunity (2013)

362 Citations

Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG

Georgia D. Tomaras;Guido Ferrari;Xiaoying Shen;S. Munir Alam.
Proceedings of the National Academy of Sciences of the United States of America (2013)

344 Citations

Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers.

Olivier Lambotte;Guido Ferrari;Christiane Moog;Nicole L Yates.
AIDS (2009)

335 Citations

Clade B-Based HIV-1 Vaccines Elicit Cross-Clade Cytotoxic T Lymphocyte Reactivities in Uninfected Volunteers

Guido Ferrari;Will Humphrey;M. Juliana McElrath;Jean–Louis Excler.
Proceedings of the National Academy of Sciences of the United States of America (1997)

309 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Guido Ferrari

David C. Montefiori

David C. Montefiori

Duke University

Publications: 213

Barton F. Haynes

Barton F. Haynes

Duke University

Publications: 202

Dan H. Barouch

Dan H. Barouch

Beth Israel Deaconess Medical Center

Publications: 169

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 164

Georgia D. Tomaras

Georgia D. Tomaras

Duke University

Publications: 144

Merlin L. Robb

Merlin L. Robb

Walter Reed Army Institute of Research

Publications: 122

Lynn Morris

Lynn Morris

University of the Witwatersrand

Publications: 117

Nelson L. Michael

Nelson L. Michael

Walter Reed Army Institute of Research

Publications: 117

Stephen J. Kent

Stephen J. Kent

University of Melbourne

Publications: 113

Bette T. Korber

Bette T. Korber

Los Alamos National Laboratory

Publications: 112

Peter B. Gilbert

Peter B. Gilbert

Fred Hutchinson Cancer Research Center

Publications: 110

Andrés Finzi

Andrés Finzi

University of Montreal

Publications: 101

M. Juliana McElrath

M. Juliana McElrath

Fred Hutchinson Cancer Research Center

Publications: 100

Galit Alter

Galit Alter

Ragon Institute of MGH, MIT and Harvard

Publications: 99

John R. Mascola

John R. Mascola

National Institutes of Health

Publications: 87

Michael S. Seaman

Michael S. Seaman

Beth Israel Deaconess Medical Center

Publications: 84

Trending Scientists

Carla E. Brodley

Carla E. Brodley

Northeastern University

Gunnar Rätsch

Gunnar Rätsch

ETH Zurich

Sergey Fomin

Sergey Fomin

University of Michigan–Ann Arbor

Noel C. MacDonald

Noel C. MacDonald

University of California, Santa Barbara

Shijie Liu

Shijie Liu

Purchase College

Kai Li

Kai Li

Zhengzhou University

Huiling Duan

Huiling Duan

Peking University

Claire Wilhelm

Claire Wilhelm

Université Paris Cité

Frédéric P. Lemaigre

Frédéric P. Lemaigre

Université Catholique de Louvain

Niall Bromage

Niall Bromage

University of Stirling

Congming Wu

Congming Wu

China Agricultural University

Christopher R. Stokes

Christopher R. Stokes

University of Bristol

Ted Hutman

Ted Hutman

University of California, Los Angeles

Choh Hao Li

Choh Hao Li

University of California, San Francisco

Lance J. Dixon

Lance J. Dixon

SLAC National Accelerator Laboratory

Something went wrong. Please try again later.